| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P2093 | author name string | Angst J | |
| Sellaro R | |||
| P2860 | cites work | Prophylactic lithium: another therapeutic myth? An examination of the evidence to date | Q70084624 |
| Prophylactic lithium | Q70088275 | ||
| Prophylactic lithium? | Q70097464 | ||
| Lithium | Q70109814 | ||
| The course of manic-depressive psychosis. A follow up investigation of 215 patients | Q72218113 | ||
| Course of the Manic-Depressive Cycle and Changes Caused by Treatments | Q72441891 | ||
| Course and outcome in bipolar affective disorder: a longitudinal follow-up study | Q72565096 | ||
| 12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode | Q74541226 | ||
| Switch from depression to mania, or from mania to depression | Q82897662 | ||
| Treatment of Depression by Drugs and Psychotherapy | Q28243322 | ||
| Transduction of psychosocial stress into the neurobiology of recurrent affective disorder | Q33969745 | ||
| Natural history of Diagnostic Interview Schedule/DSM-IV major depression. The Baltimore Epidemiologic Catchment Area follow-up | Q34445993 | ||
| Conditioning and sensitisation in the longitudinal course of affective illness | Q39747714 | ||
| Major affective disorder as a recurrent illness: a critical review | Q39912450 | ||
| Relapse in affective disorders: a reanalysis of the literature using life table methods | Q40239935 | ||
| The course and prognosis of manic-depressive psychosis: a quantitative analysis of episodes and intervals | Q40271721 | ||
| Actuarial studies of the course of manic-depressive illness | Q40920644 | ||
| The birth of the bipolar disorder | Q40998518 | ||
| Clinical course of affective disorders: were Emil Kraepelin and Jules Angst wrong? | Q41198785 | ||
| Long-term outcome of major psychoses. I. Schizophrenia and affective disorders compared with psychiatrically symptom-free surgical conditions | Q42017645 | ||
| Efficacy and safety of fluoxetine in treating bipolar II major depressive episode. | Q42537403 | ||
| Stability of diagnoses in affective, schizoaffective and schizophrenic disorders. Cross-sectional versus longitudinal diagnosis | Q43475161 | ||
| Relapse and impairment in bipolar disorder | Q43514252 | ||
| Bipolar II illness: course and outcome over a five-year period. | Q50558688 | ||
| Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. | Q50656709 | ||
| Predictors of recurrence in affective disorder. A case register study. | Q50884870 | ||
| Recurrence in affective disorder. I. Case register study. | Q50897602 | ||
| Clinical subtypes of bipolar mixed states: validating a broader European definition in 143 cases. | Q50951201 | ||
| A prospective follow-up of patients with bipolar and primary unipolar affective disorder. | Q51053324 | ||
| Evidence of chaotic mood variation in bipolar disorder. | Q51120550 | ||
| Long-term prognosis of bipolar I disorder. | Q51986583 | ||
| The likelihood of recurrence in bipolar affective disorder: the importance of episode recency. | Q52017623 | ||
| Major depression in community adolescents: age at onset, episode duration, and time to recurrence. | Q52025485 | ||
| Manic-depressive (bipolar) disorder: the course in light of a prospective ten-year follow-up of 131 patients. | Q52028648 | ||
| The life table. A method for analyzing longitudinal studies | Q52113007 | ||
| Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. | Q55051636 | ||
| Bipolar I affective disorder: predictors of outcome after 15 years | Q60447076 | ||
| Long-term stability of polarity distinctions in the affective disorders | Q60447090 | ||
| Bipolar I: A Five-Year Prospective Follow-up | Q60447096 | ||
| Differential Outcome of Pure Manic, Mixed/Cycling, and Pure Depressive Episodes in Patients With Bipolar Illness | Q60447147 | ||
| The persistent risk of chronicity in recurrent episodes of nonbipolar major depressive disorder: a prospective follow-up | Q60447163 | ||
| Episode frequency prior to lithium treatment in bipolar manic-depressive patients | Q66971969 | ||
| The course of affective disorders. II. Typology of bipolar manic-depressive illness | Q67402192 | ||
| The course of development of mania in patients with recurrent depression | Q67763566 | ||
| Characteristics and long-term follow-up of patients hospitalized for mood disorders in the Phipps Clinic, 1913-1940 | Q68187371 | ||
| Outcome in Mania. A 4-year prospective follow-up of 75 patients utilizing survival analysis | Q68610336 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bipolar disorder | Q131755 |
| P304 | page(s) | 445-457 | |
| P577 | publication date | 2000-09-01 | |
| P1433 | published in | Biological Psychiatry | Q4914961 |
| P1476 | title | Historical perspectives and natural history of bipolar disorder | |
| P478 | volume | 48 |
| Q57077038 | A gene co-expression module implicating the mitochondrial electron transport chain is associated with long-term response to lithium treatment in bipolar affective disorder |
| Q35024531 | A new bipolar spectrum concept: a brief review |
| Q44789674 | A survival analysis for recurrent events in psychiatric research |
| Q33975833 | Acute interventions and referral of patients with bipolar disorder by the psychiatric consultation liaison service in a general hospital in Germany: a retrospective analysis |
| Q35111576 | Advances in the pharmacologic treatment of bipolar depression |
| Q37608023 | American tertiary clinic-referred bipolar II disorder versus bipolar I disorder associated with hastened depressive recurrence |
| Q33533853 | Appraising evidence for intervention effectiveness in early psychosis: conceptual framework and review of evaluation approaches |
| Q43145175 | Aripiprazole as adjunct to a mood stabilizer and citalopram in bipolar depression: a randomized placebo-controlled pilot study |
| Q28478032 | Aripiprazole in the maintenance treatment of bipolar disorder: a critical review of the evidence and its dissemination into the scientific literature |
| Q34804607 | Assessment of Response to Lithium Maintenance Treatment in Bipolar Disorder: A Consortium on Lithium Genetics (ConLiGen) Report |
| Q40644004 | Atypical antipsychotics in the therapy of bipolar disorders: efficacy and safety |
| Q57244668 | Australian and New Zealand clinical practice guidelines for the treatment of bipolar disorder |
| Q34547920 | Australian and New Zealand clinical practice guidelines for the treatment of bipolar disorder |
| Q35117420 | Beyond the question of placebo controls: ethical issues in psychopharmacological drug studies |
| Q22241210 | Bipolar Disorder: An Update |
| Q21284506 | Bipolar disorder in children |
| Q73038907 | Bipolar disorder: can studies of natural history help us define clinically and neurobiologically relevant subtypes? |
| Q36390795 | Bipolar disorder: historic perspective, current pharmacologic treatment options and a review of quetiapine |
| Q35859819 | Bipolar disorders: special diagnostic and treatment considerations in women |
| Q48886105 | Bipolar mixed episodes and antidepressants: a cohort study of bipolar I disorder patients |
| Q38556588 | Changing Trends in Treatment of Acute Mania: Experience of a Tertiary Centre Over a Decade |
| Q53905947 | Chronic but not resistant mania: a case report. |
| Q44859562 | Confusing clinical presentations and differential diagnosis of bipolar disorder |
| Q38739353 | Cortisol levels in fingernails, neurocognitive performance and clinical variables in euthymic bipolar I disorder |
| Q33439865 | Daily electronic self-monitoring of subjective and objective symptoms in bipolar disorder--the MONARCA trial protocol (MONitoring, treAtment and pRediCtion of bipolAr disorder episodes): a randomised controlled single-blind trial |
| Q36250138 | Deceptive masks of bipolarity: study 100 cases |
| Q38852282 | Do the Trajectories of Bipolar Disorder and Schizophrenia Follow a Universal Staging Model? |
| Q31027146 | Does the use of an automated tool for self-reporting mood by patients with bipolar disorder bias the collected data? |
| Q38591224 | Early interventions for youths at high risk for bipolar disorder: a developmental approach |
| Q36083077 | Efficacy and Safety of Once- versus Twice-Daily Carbamazepine Extended-Release Capsules for the Treatment of Manic Symptoms in Patients with Bipolar I Disorder. |
| Q38176400 | Emerging drugs for bipolar depression: an update |
| Q36881398 | Epidemiology, diagnosis and management of mixed mania |
| Q37658892 | Epilepsy and bipolar disorders. |
| Q34676317 | Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology |
| Q35180787 | Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology |
| Q37426143 | Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology |
| Q48548437 | Feeling out of control: a qualitative analysis of the impact of bipolar disorder |
| Q37896177 | Findings from bipolar offspring studies: methodology matters |
| Q45110896 | First-episode types in bipolar disorder: predictive associations with later illness |
| Q36479843 | Fostering Recovery from Life-Transforming Mental Health Disorders: A Synthesis and Model |
| Q34318030 | From symptomatic treatments to causative therapy? |
| Q34218386 | Gender differences in unipolar depression: an update of epidemiological findings and possible explanations |
| Q38791766 | Genes Involved in Neurodevelopment, Neuroplasticity, and Bipolar Disorder: CACNA1C, CHRNA1, and MAPK1. |
| Q37199024 | Genome-wide association study identifies SESTD1 as a novel risk gene for lithium-responsive bipolar disorder |
| Q24245158 | Haloperidol alone or in combination for acute mania |
| Q24248855 | Haloperidol alone or in combination for acute mania |
| Q36376732 | Health states for schizophrenia and bipolar disorder within the Global Burden of Disease 2010 Study. |
| Q35104346 | Indianizing psychiatry - Is there a case enough? |
| Q35140930 | Interventions for Sleep Disturbance in Bipolar Disorder |
| Q43945451 | Intracerebroventricular administration of ouabain alters synaptic plasticity and dopamine release in rat medial prefrontal cortex |
| Q35212737 | Issues in the treatment of bipolar disorder |
| Q35092037 | Long-term therapy with lithium in a private practice clinic: a naturalistic study |
| Q36916509 | Longitudinal course of bipolar I disorder: duration of mood episodes |
| Q80587525 | Longitudinal research on bipolar disorders |
| Q34180785 | Longitudinal trajectories and associated baseline predictors in youths with bipolar spectrum disorders |
| Q38244115 | Maintaining mood stability in bipolar disorder: a clinical perspective on pharmacotherapy |
| Q34300315 | Mania: diagnosis and treatment recommendations |
| Q36116037 | McLean-Harvard International First-Episode Project: two-year stability of ICD-10 diagnoses in 500 first-episode psychotic disorder patients |
| Q34925397 | Mental ill health and fitness for work |
| Q57244563 | Mindfulness-Based Approaches in the Treatment of Bipolar Disorder: Potential Mechanisms and Effects |
| Q34156483 | Misdiagnosis of bipolar disorder |
| Q34374866 | Mood disorders and risk of lung cancer in the EAGLE case-control study and in the U.S. Veterans Affairs inpatient cohort |
| Q50895308 | Mood symptoms and serum lipids in acute phase of bipolar disorder in Taiwan. |
| Q24241099 | Olanzapine in long-term treatment for bipolar disorder |
| Q24250116 | Olanzapine in long-term treatment for bipolar disorder |
| Q34543895 | On the periodicity of manic-depressive insanity, by Eliot Slater (1938): translated excerpts and commentary |
| Q24242185 | Oxcarbazepine in the maintenance treatment of bipolar disorder |
| Q34404924 | P2RX7: expression responds to sleep deprivation and associates with rapid cycling in bipolar disorder type 1. |
| Q36244774 | Parental and comorbid epilepsy in persons with bipolar disorder |
| Q35933193 | Pediatric bipolar disease: current and future perspectives for study of its long-term course and treatment |
| Q84098421 | Pharmacologic treatment of bipolar disorder |
| Q44024283 | Pharmacological management of bipolar depression |
| Q34572065 | Phenomenology and diagnosis of bipolar disorder in children, adolescents, and adults: complexities and developmental issues |
| Q38098607 | Physical health of patients with bipolar disorder |
| Q97427309 | Potential pharmacogenomic targets in bipolar disorder: considerations for current testing and the development of decision support tools to individualize treatment selection |
| Q38196509 | Predicting bipolar disorder on the basis of phenomenology: implications for prevention and early intervention |
| Q98287897 | Prevalence and clinical correlates of residual symptoms in remitted patients with bipolar disorder: An exploratory study |
| Q54361559 | Prognostic models in bipolar disorder: can the prediction of the long-term clinical course rely on the integration of clinical and molecular data? |
| Q55513871 | Psychopathological Features of Bipolar Depression: Italian Validation of the Bipolar Depression Rating Scale (I-BDRS). |
| Q34165024 | Psychopharmacological Treatment Status in Outpatients with Bipolar Disorder: A Clinical Survey in Germany |
| Q35146063 | Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). |
| Q47811402 | Recent negative life events increase hair cortisol concentrations in patients with bipolar disorder |
| Q35088236 | Recovery from serious mental illness: trajectories, characteristics, and the role of mental health care |
| Q51897568 | Relationships between insight and psychosocial adjustment in patients with bipolar I disorder. |
| Q33763259 | Relative hypo- and hypercortisolism are both associated with depression and lower quality of life in bipolar disorder: a cross-sectional study |
| Q26824365 | Review of evidence for use of antidepressants in bipolar depression |
| Q35862776 | Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders |
| Q37202889 | Safety of carbamazepine extended-release capsules used in combination with other psychotropic medications for the treatment of bipolar I disorder. |
| Q48494185 | Salivary cortisol secretion in remitted bipolar patients and offspring of bipolar parents |
| Q35872076 | Scale matters: the need for a Bipolar Depression Rating Scale (BDRS). |
| Q37178416 | Scaling-up essential neuropsychiatric services in Ethiopia: a cost-effectiveness analysis |
| Q36083268 | Seasonality of Admissions for Mania: Results From a General Hospital Psychiatric Unit in Pondicherry, India |
| Q44478460 | Sertraline-induced hypomania: a genuine side-effect |
| Q35580583 | Stress, social rhythms, and behavioral activation: Psychosocial factors and the bipolar illness course |
| Q34511661 | Subsyndromal states in bipolar disorder |
| Q57244694 | Summary of Guideline for the Treatment of Bipolar Disorder |
| Q48711473 | Symptoms and treatment of bipolar patients in Sweden. |
| Q51899628 | The Bipolar Depression Rating Scale (BDRS): its development, validation and utility. |
| Q63353169 | The Cost of Relapse for Patients with a Manic/Mixed Episode of Bipolar Disorder in the EMBLEM Study |
| Q35128495 | The Mood Disorder Questionnaire: A Simple, Patient-Rated Screening Instrument for Bipolar Disorder |
| Q22241114 | The Neurobiology of the Switch Process in Bipolar Disorder |
| Q34956351 | The Wnt signaling pathway in bipolar disorder |
| Q30491262 | The association between self-reported and clinically determined hypomanic symptoms and the onset of major mood disorders |
| Q93086080 | The case for improved care and provision of treatment for people with first-episode mania |
| Q37777005 | The clinical spectrum of bipolar symptoms in epilepsy: a critical reappraisal |
| Q34042216 | The course of bipolar disorder in rural India |
| Q48344301 | The early natural history of bipolar disorder: what we have learned from longitudinal high-risk research |
| Q34289723 | The effect of mood on sleep onset latency and REM sleep in interepisode bipolar disorder |
| Q48427406 | The effect of psychoeducation on the functioning level of patients with bipolar disorder |
| Q92827078 | The effect of smartphone-based monitoring on illness activity in bipolar disorder: the MONARCA II randomized controlled single-blinded trial |
| Q38938397 | The prevalence and burden of bipolar disorder: findings from the Global Burden of Disease Study 2013. |
| Q40128111 | The prevalence of mixed episodes during the course of illness in bipolar disorder |
| Q24658110 | The role of lamotrigine in the management of bipolar disorder |
| Q47436974 | The views of early intervention service staff on the treatment of first episode bipolar disorder |
| Q51933587 | Time to remission and relapse after the first hospital admission in severe bipolar disorder. |
| Q35006376 | Toward a comprehensive clinical staging model for bipolar disorder: integrating the evidence |
| Q28646967 | Treating insomnia improves mood state, sleep, and functioning in bipolar disorder: a pilot randomized controlled trial |
| Q38093728 | Use of asenapine in clinical practice for the management of bipolar mania |
| Q28602260 | Using Smartphones to Monitor Bipolar Disorder Symptoms: A Pilot Study |
| Q48600493 | Using technology to improve longitudinal studies: self-reporting with ChronoRecord in bipolar disorder |
| Q55647096 | Web-based intervention to improve quality of life in late stage bipolar disorder (ORBIT): randomised controlled trial protocol. |
| Q36427629 | What does history teach us about factors associated with relapse in bipolar affective disorder? Presentation at Hilton hotel, Gateshead, 2 September 2005 at Symposium entitled managing The aftermath of mania |
| Q81792462 | [Bipolar and other affective disorders] |
| Q80970946 | [Factors leading to bad social outcome in subjects with psychosis] |
| Q84893412 | [Free interval and/or remission] |
| Q79905002 | [Prognostic aspects of bipolar disorders] |
| Q84893381 | [Schizophrenia and bipolar disorders: clinical dimensions] |
| Q79374866 | [The melatonin system, biological rhythms and mood disorders] |
| Q57698064 | Évolution du trouble bipolaire |
Search more.